Journal of Commercial Biotechnology

Intellectual property and biotechnology innovation: To protect or not protect?
pp. 285-286(2)
Author: Friedman, Yali

The correlation between medical tourism and biotechnology
pp. 287-289(3)
Authors: Vequist, David G; Valdez, Erika

The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview
pp. 290-292(3)
Author: Bains, William

Innovate America: The Technology Innovation Program at NIST
pp. 293-300(8)
Authors: Klein, Andrew S; Chapekar, Mrunal S

Valuation of complex license contracts
pp. 301-308(8)
Authors: Villiger, Ralph; Bogdan, Boris

How can pharmaceutical and biotechnology companies maintain a high profitability?
pp. 309-323(15)
Authors: Nickisch, Klaus J; Greuel, Joachim M; Bode-Greuel, Kerstin M

Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry
pp. 324-334(11)
Author: Glick, J Leslie

Building biotechnology teams: Personality does matter
pp. 335-346(12)
Authors: York, Anne S; McCarthy, Kim A; Darnold, Todd C

Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement
pp. 347-359(13)
Authors: Hanes, Rob; Borich, Damon

Legal and Regulatory Update
pp. 360-371(12)

Genomics & society: Legal, ethical and social dimensions
pp. 372-373(2)
Author: Clark, Dominic

Commercialization of innovative technologies: Bringing good ideas to the marketplace
pp. 374-375(2)
Author: Meyers, Arlen D

Biotech funding trends: Insights from entrepreneurs and investors
pp. 376-377(2)
Author: Glick, J Leslie